Maternal rubella-specific antibody prevalence in Ethiopian infants.
In countries with a high transmission rate of rubella the optimal age for universal rubella vaccination of infants is critically dependent upon the rate of loss of maternal antibodies. Few studies have investigated the decay characteristics of such antibodies. Mother:infant pairs were recruited at the Ethio-Swedish Children's Hospital, Addis Ababa, in 1994/95. Rubella antibody levels, determined by radial haemolysis, were available for analysis from 1542 infants aged 0-12 months, with 942 repeat measures, and from 846 mothers. Decay in seropositivity was well described by a delayed exponential function. The proportion seropositive at age 6, 9, or 12 months was 6-13%, 1-4%, or 0-1%, respectively, dependent upon assay cutoff level. Only infant age and mother's antibody level were important predictors of seropositivity. Results suggest that the success of vaccination at age 9 months or above would be little affected by residual maternal antibodies.
Kebede
S
S
Department of Pediatrics and Child Health, Addis Ababa University, Ethiopia.
Nokes
D J
DJ
Cutts
F T
FT
Nigatu
W
W
Sanderson
F
F
Beyene
H
H
D000328:Adult; D017677:Age Distribution; D000907:Antibodies, Bacterial / Q000032:analysis*; D003430:Cross-Sectional Studies; D005002:Ethiopia / Q000453:epidemiology; D005260:Female; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D016015:Logistic Models; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000453:epidemiology / Q000276:immunology*; D015995:Prevalence; D012409:Rubella / Q000453:epidemiology / Q000276:immunology*
D000907:Antibodies, Bacterial